(Q53220059)

12 May 2018

title

A proposed new strategy of immunotherapy for Alzheimer's disease. (English)

1 reference

12 May 2018

1 reference

Gasiorowski K

1

1 reference

12 May 2018

Leszek J

series ordinal

2

1 reference

12 May 2018

publication date

1 October 1997

1 reference

12 May 2018

published in

Medical Hypotheses

1 reference

12 May 2018

volume

49

1 reference

12 May 2018

page(s)

319-326

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Anti‐inflammatory agents as a therapeutic approach to Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

The complex of microglial cells and amyloid star in three-dimensional reconstruction.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Complement C1qB and C4 mRNAs responses to lesioning in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Cerebrospinal fluid microglial antibodies: potential diagnostic markers for immune mechanisms in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Immune ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Neurotrophins and cytokines--intermediaries between the immune and nervous systems

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Studies of neuroimmune markers in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Reduced natural killer cell activity in patients with dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Peripheral blood lymphocyte subset distribution and function in patients with Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Glial cytokines in Alzheimer's disease: review and pathogenic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Human brain S100 beta and S100 beta mRNA expression increases with age: pathogenic implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

T lymphocytes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Thymocyte progenitors in ageing

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Biological properties of interleukin 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Intracranial pressure and Alzheimer's disease: a hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Decreased sensitivity to dexamethasone in lymphocytes from patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Application of chemical immunomodulators to the treatment of cancer and AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

New Alzheimer's therapy suggested.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Advances in the pharmacotherapy of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Rheumatoid arthritis and susceptibility to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

A case-control study of Alzheimer's disease in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

A case-control study of Alzheimer's disease in China

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Nonsteroidal antiinflammatory drugs--differences and similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Mechanisms Underlying Long-Term Potentiation of Synaptic Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

Continuous c-fos expression precedes programmed cell death in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990198-5

7 January 2021

10.1016/S0306-9877(97)90198-5

Identifiers

DOI

1 reference

12 May 2018

PubMed ID

9352502

1 reference

12 May 2018